The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2017

Filed:

Aug. 01, 2012
Applicants:

Jay Richard Ray, Ii, Conroe, TX (US);

Charles D. Hodge, Conroe, TX (US);

Inventors:

Jay Richard Ray, II, Conroe, TX (US);

Charles D. Hodge, Conroe, TX (US);

Assignee:

CMPD Licensing, LLC, Conroe, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/54 (2006.01); A61K 9/00 (2006.01); A61K 31/5415 (2006.01); A61K 31/167 (2006.01); A61K 31/53 (2006.01); A61K 31/7048 (2006.01); A61K 9/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/167 (2013.01); A61K 31/53 (2013.01); A61K 31/5415 (2013.01); A61K 31/7048 (2013.01);
Abstract

The present embodiments relate to topically delivered compounded medications. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The transdermal cream may include low concentrations of local anesthetics, a NSAID, an anticonvulsant, and/or other active ingredients. For instance, the transdermal cream may include lidocaine, prilocaine, meloxicam, and lamotrigine and/or topiramate. Alternatively, the transdermal cream may include a lidocaine/prilocaine base cream to which is added a fine powder of one or more ground up medications to form a compounded medication. The compounded medication in powder form may be generated from grinding up tablets of NSAIDs, anticonvulsants, nerve depressants, antidepressants, muscle relaxants, NMDA receptor antagonists, opiate or opioid agonists, and/or other agents. The compounded medication in powder form may include meloxicam, lamotrigine, topiramate, and/or other active ingredients. In another aspect, the present embodiments relate to methods of compounding medications and transdermal creams or gels.


Find Patent Forward Citations

Loading…